| 12016856 |
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
Marc Navre, Christopher Carreras, Noah Bell, Michael R. Leadbetter, Jeffrey W. Jacobs |
2024-06-25 |
$26,595,000 |
| 11813304 |
Compounds and methods for inhibiting phosphate transport |
Jason G. Lewis, Jeffrey W. Jacobs, Ingrid Langsetmo, Christopher Carreras |
2023-11-14 |
$19,266,000 |
| 11318129 |
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
Marc Navre, Christopher Carreras, Noah Bell, Michael R. Leadbetter, Jeffrey W. Jacobs |
2022-05-03 |
$3,420,000 |
| 10940146 |
NHE3-binding compounds and methods for inhibiting phosphate transport |
Christopher Carreras, Jeffrey W. Jacobs, Eric Labonte, Jason G. Lewis |
2021-03-09 |
$8,599,000 |
| 10905711 |
Methods and compositions for selectively removing potassium ion from the gastrointestinal tract of a mammal |
Michael J. Cope, Paul Mansky, Futian Liu, Han-Ting Chang, Eric Connor +4 more |
2021-02-02 |
|
| 10543207 |
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
Marc Navre, Christopher Carreras, Noah Bell, Michael R. Leadbetter, Jeffrey W. Jacobs |
2020-01-28 |
$15,420,000 |
| 10485821 |
Ion binding polymers and uses thereof |
Han-Ting Chang, Gerrit Klaerner, Jerry M. Buysse, Mingjun Liu |
2019-11-26 |
|
| 10385024 |
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
Noah Bell, Christopher Carreras, Tao Chen, Michael R. Leadbetter, Jeffrey W. Jacobs +1 more |
2019-08-20 |
$3,346,000 |
| 10272079 |
NHE3-binding compounds and methods for inhibiting phosphate transport |
Christopher Carreras, Jeffrey W. Jacobs, Eric Labonte, Jason G. Lewis |
2019-04-30 |
$3,315,000 |
| 10058567 |
Methods and compositions for selectively removing potassium ion from the gastrointestinal tract of a mammal |
Michael J. Cope, Paul Mansky, Futian Liu, Han-Ting Chang, Eric Connor +6 more |
2018-08-28 |
|
| 9919006 |
Compositions and methods for treating hyperkalemia |
James P. Davidson, Fangling Lin, Jeffrey W. Jacobs, Natalia Blinova, Eric Labonte +2 more |
2018-03-20 |
$5,466,000 |
| 9867848 |
Compositions and methods for treating hyperkalemia |
James P. Davidson, Fangling Lin, Jeffrey W. Jacobs, Natalia Blinova, Eric Labonte +2 more |
2018-01-16 |
$7,082,000 |
| 9655921 |
Compositions and methods for treating hyperkalemia |
James P. Davidson, Fangling Lin, Jeffrey W. Jacobs, Natalia Blinova, Eric Labonte +2 more |
2017-05-23 |
$4,026,000 |
| 9549947 |
Pharmaceutical compositions for treating hyperkalemia |
James P. Davidson, Fangling Lin, Jeffrey W. Jacobs, Natalia Blinova, Eric Labonte +2 more |
2017-01-24 |
$8,219,000 |
| 9545425 |
Pharmaceutical compositions for treating hyperkalemia |
James P. Davidson, Fangling Lin, Jeffrey W. Jacobs, Natalia Blinova, Eric Labonte +2 more |
2017-01-17 |
$9,679,000 |
| 9433640 |
Compositions and methods for treating hyperkalemia |
James P. Davidson, Fangling Lin, Jeffrey W. Jacobs, Natalia Blinova, Eric Labonte +2 more |
2016-09-06 |
$8,658,000 |
| 9408840 |
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorder |
Noah Bell, Christopher Carreras, Jeffrey W. Jacobs, Michael R. Leadbetter, Marc Navre |
2016-08-09 |
$7,926,000 |
| 9301974 |
Methods and compositions for selectively removing potassium ion from the gastrointestinal tract of a mammal |
Michael J. Cope, Paul Mansky, Futian Liu, Han-Ting Chang, Eric Connor +4 more |
2016-04-05 |
$20,063,000 |
| 9301951 |
Compounds and methods for inhibiting phosphate transport |
Jason G. Lewis, Jeffrey W. Jacobs, Nicholas Reich, Michael R. Leadbetter, Noah Bell +5 more |
2016-04-05 |
$5,562,000 |
| 9289429 |
Compounds and methods for inhibiting phosphate transport |
Jason G. Lewis, Jeffrey W. Jacobs, Nicholas Reich, Michael R. Leadbetter, Noah Bell +5 more |
2016-03-22 |
$2,576,000 |
| 9289430 |
Compounds and methods for inhibiting phosphate transport |
Jason G. Lewis, Jeffrey W. Jacobs, Nicholas Reich, Michael R. Leadbetter, Noah Bell +5 more |
2016-03-22 |
$2,576,000 |
| 9278102 |
Compounds and methods for inhibiting phosphate transport |
Jason G. Lewis, Jeffrey W. Jacobs, Nicholas Reich, Michael R. Leadbetter, Noah Bell +5 more |
2016-03-08 |
$5,895,000 |
| 9006281 |
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
Noah Bell, Christopher Carreras, Jeffrey W. Jacobs, Michael R. Leadbetter, Marc Navre |
2015-04-14 |
$5,257,000 |
| 8969377 |
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
Noah Bell, Christopher Carreras, Jeffrey W. Jacobs, Michael R. Leadbetter, Marc Navre |
2015-03-03 |
$7,073,000 |
| 8916569 |
Compounds and methods for inhibiting phosphate transport |
Jason G. Lewis, Jeffrey W. Jacobs, Nicholas Reich, Michael R. Leadbetter, Noah Bell +5 more |
2014-12-23 |
$9,357,000 |